Clinical Trial Update: Multicenter Real-life Observational Study Switched Aflibercept or Ranibizumab to Faricimab in Patients With AMD.

View source ↗

Summary

A multicenter real-world observational study is evaluating switching patients with age-related macular degeneration from aflibercept or ranibizumab to faricimab…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Aflibercept (Aflibercept)
• Faricimab (faricimab)
• Ranibizumab (ranibizumab)

Snippet

Sponsor: Nantes University Hospital | Conditions: Age-related Macular Degeneration | Status: RECRUITING